VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO Breast 2022 | Immunotherapy insights from ESMO Breast 2022

Céline Blaye • 4 May 2022
ESMO Breast 2022
Breast Cancer
Immuno-Oncology

Céline Blaye, MD, University of Bordeaux, Bordeaux, France, on what she enjoyed most at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 meeting. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.

More from Céline Blaye

1:23
Exploring myeloid cells to reverse the hormone-mediated microenvironemnt of luminal breast cancer
Céline Blaye • 4 May 2022
1:30
The role of myeloid-derived suppressor cells in breast cancer
Céline Blaye • 4 May 2022
1:22
Immunological signatures to predict outcomes in patients with TNBC
Céline Blaye • 4 May 2022

Related Videos

1:22
Advancing cancer therapeutics for brain metastases
Bently Doonan • 14 Jun 2022
4:25
DESTINY-Breast03: safety follow-up results
Erika Hamilton • 10 Jun 2022
2:01
DESTINY-Breast04: practice-changing results for HER2-low breast cancer
Erika Hamilton • 10 Jun 2022
0:55
HER2CLIMB-05: tucatinib with trastuzumab and pertuzumab as maintenance therapy for HER2+ mBC
Erika Hamilton • 10 Jun 2022
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals